Drugs / LongShengZhi
last change Jun 2024 re-read 3 minutes ago

LongShengZhi

Developed for
ischemic stroke
Investigated by
Dongzhimen Hospital, Beijing

Trials 1

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT05277311 May 2022 → Dec 2023 ischemic stroke Dongzhimen Hospital, Beijing Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LongShengZhi ClinicalTrials.gov intervention name — accepted as the source's own label NCT05277311 ↗
Route Oral “orally” NCT05277311 ↗